The SBF2 gene helps support the fatty covering around peripheral nerves and the movement of materials inside cells. In medicine, this gene is important because it helps regulate nerve maintenance, especially in the legs and feet. If it does not work properly, a person may develop an inherited nerve condition called Charcot-Marie-Tooth disease type 4B2, which can lead to weakness, numbness, foot shape changes, and walking difficulties. SBF2 is mainly known in neurology and genetics rather than in everyday public culture.
What is a gene?
Genes are pieces of DNA that give your cells instructions for making molecules or regulating processes in the body. Some genes carry the information needed to make proteins, which do much of the cell’s work. Others mainly control when certain processes happen, where they occur, and how active they are. Taken together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. For a more detailed look at this topic, you can find more in the LearnHub.
Overview
SBF2Gene function
What if the gene works
The SBF2 gene helps support healthy peripheral nerves. Its protein works with related proteins to manage membrane trafficking inside Schwann cells, which helps maintain myelin, the insulating layer around nerves.
Risk
What if the gene does not work
Variants in the SBF2 gene can cause Charcot-Marie-Tooth disease type 4B2, a condition affecting peripheral nerves that often leads to weakness, numbness, and foot changes in childhood or early adulthood. Milder to more severe variants can influence onset and severity.
Treatment
What does that mean for your treatment
No SBF2-specific treatment or drug selection approach is currently established for pathogenic variants in the SBF2 gene. Care is guided by a person’s symptoms and supportive needs rather than a gene-directed medicine.
Conditions associated with SBF2
Gene function
What if the gene works
Inside your cells, the SBF2 gene helps organize how membranes are handled and recycled. It mainly works as a helper protein, guiding other proteins that control signal fats on internal membranes. Understanding SBF2 gene function helps show how cells keep cargo moving in an orderly way, especially in nerve-supporting cells.
The SBF2 gene makes a helper protein that teams up with MTMR2, another protein involved in membrane control. This pairing helps direct where that work happens inside the cell.
It helps cells manage signal fats on internal membranes. These fats act like location tags, helping each cell compartment keep the right identity.
SBF2 supports endosomes (small sorting compartments inside cells) as they move and recycle cell material. This helps proteins and membrane pieces reach the right place.
In cells that insulate peripheral nerves, SBF2 helps maintain layered membranes called myelin (the nerve's protective covering). This supports smooth message flow along nerves.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help create normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, however, a variant can change how a gene functions more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
In SBF2-related neuropathy, many variants in the SBF2 gene reduce or stop production of the SBF2 protein, while some milder changes leave part of it working. These differences help explain how variants in the SBF2 gene affect nerve cells: more disruptive variants can more strongly disturb membrane recycling in Schwann cells, the cells that wrap nerves, leading to abnormal myelin folding. Milder variants may preserve some protein activity and are often linked to later onset or less severe features.
How variants are linked to conditions
Pathogenic variants in the SBF2 gene cause Charcot-Marie-Tooth disease type 4B2, a rare inherited nerve condition that can lead to weakness, foot shape changes, and reduced feeling in the legs and feet. The link between SBF2 gene variants and Charcot-Marie-Tooth disease type 4B2 is well established in human genetics. In some families, early-onset glaucoma is also reported.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common throughout the general population. Most do not have a direct effect on health and instead represent natural human diversity. For many genes, carrying a variant associated with a condition points to a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SBF2-related nerve conditions, risk is mainly shaped by the genetic change itself rather than by lifestyle. Risk is higher if both parents carry an SBF2 variant, while there is not enough evidence to say that diet, exercise, or other everyday factors lower the chance of developing the condition.
Inheritance of SBF2 variants
Variants in the SBF2 gene are inherited in an autosomal recessive pattern for the best known SBF2-related condition, a form of inherited peripheral neuropathy called Charcot-Marie-Tooth disease type 4B2. This means a person usually inherits one nonworking copy from each parent. Parents who each carry one SBF2 gene variant are often unaffected, and with each pregnancy there is a 25% chance the child will inherit both variants, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither variant.
What does my SBF2 result mean for my family?
Changes in the SBF2 gene are linked to a rare inherited nerve condition that usually runs in families in a recessive pattern. For family members, this often means parents may be healthy carriers, and brothers or sisters could also have the condition or be carriers. Other relatives may also carry the gene change, especially on the same side of the family.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the SBF2 gene uses a blood sample, saliva, or a cheek swab to read the DNA code in this gene. It can show whether you carry a variant linked to certain inherited nerve conditions and may help clarify a diagnosis or family risk. Results are interpreted alongside your symptoms and family history.
When should I consider getting a genetic test?
Consider testing for the SBF2 gene if you or your child has signs of an inherited nerve condition, such as slowly worsening foot weakness, numbness, frequent tripping, or high-arched feet, especially if symptoms started early in life. Testing can also help when there is a family history of Charcot-Marie-Tooth disease or a related nerve condition.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it can tell you varies with the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also influence how the body functions. In some conditions, particularly those shaped by many genes, genetic information offers context rather than certainty and makes the most sense when considered with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone who is more sensitive.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It looks at gene and drug patterns to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body handles it. This information can support more informed, more individualized treatment decisions. If you want to learn more about this topic, you can explore it further in the LearnHub.
Drugs influenced by the SBF2 gene
When should I seek medical advice?
There is no broadly confirmed role for this gene in predicting medication response, so questions about side effects, new symptoms, or changes to your treatment are best discussed with your doctor.
History
The SBF2 gene entered the medical literature through research on inherited nerve conditions, especially rare forms of Charcot-Marie-Tooth disease. In the early 2000s, scientists linked variants in the SBF2 gene to Charcot-Marie-Tooth disease type 4B2, helping clarify why some families developed early weakness and changes in the nerves’ insulating covering. From these first observations, research expanded steadily, and SBF2 became recognized as part of a small group of related genes involved in inherited neuropathy. The gene has also been known by the name MTMR13 in earlier studies, which can still appear in older reports. Over time, descriptions became more precise as genetic testing improved and helped confirm the diagnosis in affected families.